Arteris (NASDAQ:AIP) Director Saiyed Atiq Raza Sells 90,000 Shares

Key Points

• Arteris director Saiyed Atiq Raza sold 90,000 shares on May 1 at an average price of $28.71 for about $2.58M, cutting his holding to 210,000 shares (a 30% reduction); the trade was executed under a pre‑arranged Rule 10b5‑1 plan and disclosed to the SEC.
• He has been liquidating sizeable positions since late February — selling roughly 380,000 shares through May 1 — signaling sustained insider disposals over the period.
• Arteris stock trades near $28.85 (close to its one‑year high of $29.50) and is well above the analysts' average target of $20.17, despite a recent quarter where the company beat revenue and EPS estimates.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) Director Saiyed Atiq Raza sold 90,000 shares of the business's stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $28.71, for a total value of $2,583,900.00. Following the completion of the sale, the director directly owned 210,000 shares of the company's stock, valued at approximately $6,029,100. This trade represents a 30.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Saiyed Atiq Raza also recently made the following trade(s):

• On Monday, April 20th, Saiyed Atiq Raza sold 17,060 shares of Arteris stock. The shares were sold at an average price of $22.16, for a total value of $378,049.60.
• On Friday, April 17th, Saiyed Atiq Raza sold 72,940 shares of Arteris stock. The shares were sold at an average price of $22.16, for a total value of $1,616,350.40.
• On Wednesday, March 4th, Saiyed Atiq Raza sold 3,690 shares of Arteris stock. The shares were sold at an average price of $17.02, for a total value of $62,803.80.
• On Monday, March 2nd, Saiyed Atiq Raza sold 106,031 shares of Arteris stock. The shares were sold at an average price of $17.21, for a total value of $1,824,793.51.
• On Friday, February 27th, Saiyed Atiq Raza sold 11,762 shares of Arteris stock. The shares were sold at an average price of $17.01, for a total value of $200,071.62.
• On Thursday, February 26th, Saiyed Atiq Raza sold 73,610 shares of Arteris stock. The shares were sold at an average price of $17.14, for a total value of $1,261,675.40.
• On Wednesday, February 25th, Saiyed Atiq Raza sold 4,907 shares of Arteris stock. The shares were sold at an average price of $17.00, for a total value of $83,419.00.

Arteris Stock Down 0.3%

Shares of NASDAQ AIP traded down $0.10 during midday trading on Monday, reaching $28.85. The company had a trading volume of 685,826 shares, compared to its average volume of 520,823. The stock has a market cap of $1.33 billion, a PE ratio of -35.18 and a beta of 1.93. Arteris, Inc. has a one year low of $6.64 and a one year high of $29.50. The firm's fifty day moving average price is $18.51 and its 200-day moving average price is $16.40.

Arteris (NASDAQ:AIP - Get Free Report) last announced its quarterly earnings results on Thursday, February 12th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.08) by $0.03. The business had revenue of $20.14 million for the quarter, compared to analysts' expectations of $18.55 million. As a group, equities research analysts expect that Arteris, Inc. will post -0.68 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Strs Ohio grew its holdings in shares of Arteris by 65.9% during the 1st quarter. Strs Ohio now owns 34,000 shares of the company's stock worth $559,000 after acquiring an additional 13,500 shares during the period. Wesbanco Bank Inc. purchased a new position in shares of Arteris during the 1st quarter worth approximately $559,000. Invesco Ltd. grew its holdings in shares of Arteris by 28.0% during the 4th quarter. Invesco Ltd. now owns 17,499 shares of the company's stock worth $271,000 after acquiring an additional 3,830 shares during the period. Mercer Global Advisors Inc. ADV purchased a new position in shares of Arteris during the 4th quarter worth approximately $162,000. Finally, VestGen Advisors LLC purchased a new position in shares of Arteris during the 4th quarter worth approximately $218,000. Hedge funds and other institutional investors own 64.36% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on AIP shares. Wall Street Zen downgraded Arteris from a "buy" rating to a "hold" rating in a report on Saturday. Rosenblatt Securities reissued a "buy" rating and set a $20.00 price objective on shares of Arteris in a research report on Friday, February 13th. Northland Securities set a $24.00 price objective on shares of Arteris in a report on Friday, February 13th. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Arteris in a research report on Monday, April 20th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $20.17.

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.